Brought to you by 
Speedel raises $13.4mm in second round
20 Feb 2002
Executive Summary
Speedel Group (cardiovascular and metabolic drug development) raised $13.4mm (CHF22.2mm) in a second round of financing from the Novartis Venture Fund and other returning private investors.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Speedel raises $13.4mm in second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice